A Randomized Double-Blind Placebo-Controlled Trial of Dipeptidyl Peptidase-1 Inhibition in Hospitalized Patients with COVID-19: The STOP-COVID19 Trial

H. R. Keir (Lead / Corresponding author), M. B. Long, H. Abo leyah, Y. H. Giam, T. Vadiveloo, T. Pembridge, R. Hull, L. Delgado, M. Band, F. Mclaren-Neill, S. Adamson, E. Lahnsteiner, A. Gilmour, C. Hughes, B. J. M. New, D. Connell, R. Dowey, H. Turton, H. Richardson, D. CassidyJ. Cooper, J. Suntharalingam, L. Diwakar, P. Russell, J. Underwood, A. Hicks, D. P. Dosanjh, E. Sage, D. Dhasmana, M. Spears, R. Thompson, C. Brightling, M. Patel, J. George, A. M. Condliffe, A. Shoemark, G. Maclennan, J. D. Chalmers

Research output: Contribution to conference › Paper › peer-review

Fingerprint

Dive into the research topics of 'A Randomized Double-Blind Placebo-Controlled Trial of Dipeptidyl Peptidase-1 Inhibition in Hospitalized Patients with COVID-19: The STOP-COVID19 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences